Show Summary Details
Page of

Contraception Options in Neurologic Disease 

Contraception Options in Neurologic Disease
Contraception Options in Neurologic Disease

Tessa L. Reisinger

, and Amy Robinson Harrington

Page of

PRINTED FROM OXFORD MEDICINE ONLINE ( © Oxford University Press, 2021. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 02 March 2021

Unplanned pregnancy has particular implications for women with chronic disease, including increased risk of adverse health events during pregnancy and potential impact on disease course or treatment options. While preventing unplanned pregnancy is especially important in this population, both medications and sequelae of chronic disease must be considered in choosing safe and effective contraceptive options. The US Medical Eligibility Criteria for Contraceptive Use were established to provide guidance on contraceptive use for women with various disease conditions; however, specific guidelines for many neurologic conditions are limited. This chapter reviews evidence and recommendations for contraception options in women with a wide range of neurologic conditions. Considerations include interactions with medications, the risk of venous thromboembolism in the setting of reduced mobility, and the impact of hormonal contraception on symptom frequency and disease progression. In many cases, long-acting reversible contraception (LARC) methods offer highly effective, well-tolerated contraception for women with neurologic disease.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.